About the Institute


UMP - Image - Size 5 - Urology Konety Hallway

A Full Range of Treatment Options

At the Institute for Prostate and Urologic Cancers, our combined emphasis on clinical care, research and education allows us to stand at the forefront of compassionate, innovative care, with a shared vision to make a real difference in the lives of our patients with prostate cancer. Treatment options available at the Institute for Prostate and Urologic Cancers are discussed in detail under Clinical Services.

Surgical specialists from University of Minnesota Physicians also strive to improve prostate cancer treatments through the advancement of surgical techniques. For instance, robotic technology used in radical prostatectomies gives the surgeon greater precision and improved dexterity with enhanced 3D visualization. With this minimally invasive approach, patients may experience less pain, shorter recovery times and fewer complications.

Innovation and Discovery Bring New Options to Patients

Our physicians are active researchers and members of the Masonic Cancer Center, University of Minnesota, one of only 41 National Cancer Institute (NCI) Comprehensive Cancer Centers in the nation. Building upon this strong foundation, the Institute for Prostate and Urologic Cancers continually improves patient treatment methods, giving you access to the latest in cancer prevention, detection and treatment options, as well as the opportunity to participate in clinical trials.

We Work With Your Physician

The team at the Institute for Prostate and Urologic Cancers works in cooperation with your primary care physician for all treatment plans. After your initial consultation with our physician, a detailed letter with a visit summary and explanation of the recommended treatment plan is sent to your primary care physician.

We will ask your primary care physician to assist us with a complete history and physical along with medical clearance prior to beginning any treatment. This is especially important if you have any history of cardiac problems, lung disease, vascular disease, or bleeding.

About Prostate Cancer

Prostate cancer has become the most commonly diagnosed cancer among men in the U.S. It usually grows slowly. Men who have it often die from other causes before the cancer kills them. Still, prostate cancer is one of the most common causes of cancer death in American men. The prostate cancer death rate is especially high among African American men.

Risk Factors

Men at highest risk for this type of cancer fall into four categories:

  • Men living in the United States, as they have the highest rate of this disease of any country in the world
  • Men with a family history of prostate cancer
  • African-American men
  • Older men

The American Cancer Society recommends that any man living in the U.S. should be screened for prostate cancer beginning at age 50 with a PSA blood test and digital rectal exam (DRE). Screening should begin earlier, at age 40, for African Americans or those with a family history of prostate cancer. Some men may need testing by age 40 if they carry a high risk (family history or African American descent). Early screening can significantly improve your chance of catching cancer at an early, curable stage and can also set up a baseline of test scores so doctors can see any important changes.

Screening and Diagnosis

Prostate cancer typically produces very few symptoms and they are very similar to those of benign prostatic hyperplasia (BPH), a non-cancerous condition. When symptoms appear, it usually indicates the cancer has become more advanced.

Symptoms may include:

  • urinary problems
  • dull pain in the back, hips, thighs or pelvic area
  • blood in the urine or semen
  • bone pain

Through screening tests, doctors are able to find prostate cancer at earlier stages of growth than ever before, usually before symptoms ever start. Screening and diagnostic services available at The Center for Prostate Cancer are discussed in detail under Clinical Services.

About the Director

The Institute for Prostate and Urologic Cancers is directed by urologic cancer surgeon Badrinath Konety, M.D., M.B.A., of University of Minnesota Physicians. His extensive experience in cancer and urology combined with his research in screening, treatment and management of prostate and bladder cancer will foster innovative patient care in all areas of urology.


 
 

Central Scheduling: 612.672.7422

Provider Referrals: 612.672.7000

Administrative Offices: 612.884.0600
 

©2012 Regents of the University of Minnesota. All rights reserved.